LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 41.11 | 27.76 | 2348 | 3331 | 0.7048 | 0.9012 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 41.11 | 27.76 | 2368 | 3331 | 0.7108 | 0.9036 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 41.11 | 27.76 | 772 | 3331 | 0.2317 | 0.6184 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 41.11 | 27.76 | 2911 | 3331 | 0.8738 | 0.9613 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 42.81 | 27.76 | 2487 | 3596 | 0.6916 | 0.8976 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 42.81 | 27.76 | 2500 | 3596 | 0.6952 | 0.8990 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 42.81 | 27.76 | 877 | 3596 | 0.2439 | 0.6357 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 42.81 | 27.76 | 3098 | 3596 | 0.8614 | 0.9579 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 44.52 | 27.76 | 2682 | 3884 | 0.6905 | 0.8987 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 44.52 | 27.76 | 2703 | 3884 | 0.6959 | 0.9008 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 44.52 | 27.76 | 1016 | 3884 | 0.2616 | 0.6570 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 44.52 | 27.76 | 3340 | 3884 | 0.8599 | 0.9581 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 46.22 | 27.76 | 2899 | 4125 | 0.7028 | 0.9046 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 46.22 | 27.76 | 2914 | 4125 | 0.7064 | 0.9060 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 46.22 | 27.76 | 1023 | 4125 | 0.2480 | 0.6486 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 46.22 | 27.76 | 3601 | 4125 | 0.8730 | 0.9627 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 47.93 | 27.76 | 3164 | 4421 | 0.7156 | 0.9106 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 47.93 | 27.76 | 3182 | 4421 | 0.7197 | 0.9121 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 47.93 | 27.76 | 1238 | 4421 | 0.2800 | 0.6806 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 47.93 | 27.76 | 3870 | 4421 | 0.8753 | 0.9639 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 49.63 | 27.76 | 3366 | 4818 | 0.6986 | 0.9059 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 49.63 | 27.76 | 3383 | 4818 | 0.7022 | 0.9072 | MN20160318_Q01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 49.63 | 27.76 | 1283 | 4818 | 0.2663 | 0.6741 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 49.63 | 27.76 | 4115 | 4818 | 0.8541 | 0.9580 | MN20160318_Q01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 51.33 | 27.76 | 3606 | 5117 | 0.7047 | 0.9091 | MN20160318_Q01 | I06 |